Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarction

This publication has 27 references indexed in Scilit:

• Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique
  Published by Elsevier ,2004
• Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.
  Circulation, 1981
• Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs.
  Circulation Research, 1981
• Demonstration of lateral and epicardial border zone salvage by flurbiprofen using an in vivo method for assessing myocardium at risk.
  Circulation, 1981
• Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart.
  Circulation Research, 1980
• Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion.
  Proceedings of the National Academy of Sciences, 1980
• ANTI‐AGGREGATORY EFFECT OF PROSTACYCLIN (PGI₂) in vivo
  British Journal of Pharmacology, 1979
• De-aggregatory action of prostacyclin and its enhancement by theophylline
  Prostaglandins, 1978
• Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid
  Prostaglandins, 1977
• HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
  The Lancet, 1977